Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

15 citing papers in PubMed.

1. Impact of Chemical Aging on Venison Processing Knife Topography and Recoverable Chronic Wasting Disease Prion Seeding Activity.Pathogens (Basel, Switzerland) · 2026
   Article
2. Recent advancements in QuIC-based diagnostic assays for sporadic and inherited prion diseases: focusing on the emerging role of ES-QuIC.Frontiers in neuroscience · 2026
   Review
3. Exploring ethical, sustainable and effective foetal bovine serum alternatives forFrontiers in toxicology · 2026
   Review
4. Bovine spongiform encephalopathy: A review of current knowledge and challenges.Open veterinary journal · 2025
   Review
5. The importance of ongoing international surveillance for Creutzfeldt-Jakob disease.Nature reviews. Neurology · 2021
   Review
6. Consumer reactions to risk information on bovine spongiform encephalopathy in Japan.Environmental health and preventive medicine · 2010
   Article
7. Risk behaviors in a rural community with a known point-source exposure to chronic wasting disease.Environmental health : a global access science source · 2008
   Article
8. Oral transmissibility of prion disease is enhanced by binding to soil particles.PLoS pathogens · 2007
   Article
9. Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE) in the management of hemophilia A.Vascular health and risk management · 2007
   Review
10. BSE safety standards: An evaluation of public health policies of Japan, Europe, and USA.Environmental health and preventive medicine · 2005
    Article
11. Why aren't we more ahead? The risk of variant Creutzfeldt-Jakob disease from eating bovine spongiform encephalopathy-infected foods: still undetermined.European journal of epidemiology · 2004
    Article
12. Animal transmissible spongiform encephalopathies and genetics.Veterinary research communications · 2003
    Article
13. The new variant of the Creutzfeldt-Jakob disease accounts for no relative increase of the Creutzfeldt-Jakob disease mortality rate in the United Kingdom; this fits ill with the new variant being the consequence of consumption of food infected with the agent of Bovine Spongiform Encephalopathy.BMC public health · 2003
    Article
14. New variant Creutzfeldt-Jakob disease: the epidemic that never was.BMJ (Clinical research ed.) · 2001
    Review
15. BSE and variant CJD. Assumption that BSE originated from scrapie in sheep led to misjudgment.BMJ (Clinical research ed.) · 2001
    Article

Corrections and comments

• Commented on by
  BSE and variant CJD. Assumption that BSE originated from scrapie in sheep led to misjudgment.2001
• Commented on by
  BSE and variant CJD. Humans can live with BSE so long as they do not eat brains.2001

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as